Merck has announced that the US Food and Drug Administration [...]
AC Immune SA has reported positive interim results from [...]
Gilead Sciences has announced positive topline results from the Phase [...]
EG 427 has released encouraging first clinical data from its [...]
Takeda’s antibody-drug conjugate gains second frontline indication following positive Phase [...]